Journals / Solunum / 2014 / Cilt: 16 - Sayı: 1

Co-occurrence of Chronic Obstructive Pulmonary Disease and Bronchiectasis: Is It a New Phenotype of Chronic Obstructive Pulmonary Disease?

Journal
Solunum
Pages
8–12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Many authors observed high prevalence of bronchiectasis in COPD patients showing association with increased inflammation, more severe and longer exacerbations, higher colonization of bronchial mucosa with potential pathogenic bacteria, and, the most important, with poorer prognosis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Bronchiectasis and chronic obstructive pulmonary disease (COPD) share many pathophysiological, clinical and spirometric characteristics.
📊
Key Findings & Data:Along with the increasing and widespread use of high resolution computed tomography (HRCT) scanning, bronchiectasis has become more detectable in patients presenting with chronic cough and shortness of breath.
💡
Conclusion & Impact:Many authors observed high prevalence of bronchiectasis in COPD patients showing association with increased inflammation, more severe and longer exacerbations, higher colonization of bronchial mucosa with potential pathogenic bacteria, and, the most important, with poorer prognosis
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Bronchiectasis and chronic obstructive pulmonary disease (COPD) share many pathophysiological, clinical and spirometric characteristics. Along with the increasing and widespread use of high resolution computed tomography (HRCT) scanning, bronchiectasis has become more detectable in patients presenting with chronic cough and shortness of breath. Identification of different phenotypes of COPD is important in terms of both therapeutic options and clinical outcomes of the disease. Co-occurrence of chronic obstructive pulmonary disease and bronchiectasis might be a different phenotype with more severe COPD and poorer prognosis. Many authors observed high prevalence of bronchiectasis in COPD patients showing association with increased inflammation, more severe and longer exacerbations, higher colonization of bronchial mucosa with potential pathogenic bacteria, and, the most important, with poorer prognosis

🔖

Cite This Article

TÜLEK, B. (2014). Co-occurrence of Chronic Obstructive Pulmonary Disease and Bronchiectasis: Is It a New Phenotype of Chronic Obstructive Pulmonary Disease?. Solunum, Cilt: 16 - Sayı: 1, 8–12. https://ajindex.com/articles/314509

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. GOLD. Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2013. (cited: 2013 March 30) Available from: URL: http://www.goldcopd.org. Chonic obstructive pulmonary disease (COPD). (cited: 2013 April 4). Available from: URL: http://www.who.int/mediacentre/factsheets/fs315/ en/index.html. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-12. [CrossRef] Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167: 544-9. [CrossRef] Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: find- ings from the Copenhagen city heart study. Am J Respir Crit Care Med 2006; 173: 79-83. [CrossRef] Domingo-Salvany A, Lamarca R, Ferrer M, Garcia-Aymerich J, Alonso J, Felez M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166: 680-5. [CrossRef] Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidi- ties in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5: 549-55. [CrossRef] Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-31. [CrossRef] Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 250-5. [CrossRef] Weycker D, Edelsberg J. Oster G, Tino G. Prevalence and economic bur- den of bronchiectasis. Clin Pulm Med 2005; 205-9.
  2. Novosad SA, Barker AF. Chronic obstructive pulmonary disease and bronchiectasis. Curr Opin Pulm Med 2013; 19: 133-9. [CrossRef] Martinez-Garcia MA, Soler-Cataluna JJ, Donat Sanz Y, Catalan Serra P, Agramunt Lerma M, Ballestin Vicente J, et al. Factors associated with bron- chiectasis in patients with COPD. Chest 2011; 140: 1130-7. [CrossRef] Martinez-Garcia MA, de la Rosa D, Soler-Cataluna JJ,